Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of income and expense [abstract] | ||||||||||||||||||
| Revenue [abstract] | ||||||||||||||||||
| Revenue | — |
63,276
EUR
|
— | — | — | — | — | — | — | — | — |
69,815
EUR
|
— | — | — | — | — | — |
| Expenses by nature [abstract] | ||||||||||||||||||
| Classes of employee benefits expense [abstract] | ||||||||||||||||||
| Employee benefits expense | — |
2,167
EUR
|
— | — | — | — | — | — | — | — | — |
2,344
EUR
|
— | — | — | — | — | — |
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||||||||||||||||||
| Depreciation and amortisation expense [abstract] | ||||||||||||||||||
| Depreciation and amortisation expense | — |
41,078
EUR
|
— | — | — | — | — | — | — | — | — |
39,855
EUR
|
— | — | — | — | — | — |
| Other expenses, by nature | — |
19,138
EUR
|
— | — | — | — | — | — | — | — | — |
13,313
EUR
|
— | — | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||||||||||||||||||
| Disclosure of attribution of expenses by nature to their function [line items] | ||||||||||||||||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||||||||||||||||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method | — |
11,000
EUR
|
— | — | — | — | — | — | — | — | — |
257,000
EUR
|
— | — | — | — | — | — |
| Income tax relating to components of other comprehensive income [abstract] | ||||||||||||||||||
| Income tax relating to components of other comprehensive income that will be reclassified to profit or loss | — |
1,127
EUR
|
— | — | — | — | — | — | — | — | — |
1,600
EUR
|
— | — | — | — | — | — |
| Comprehensive income, continuing and discontinued operations [abstract] | ||||||||||||||||||
| Comprehensive income |
506,000
EUR
|
1,751
EUR
|
0
EUR
|
0
EUR
|
EUR
|
2,706
EUR
|
2,000
EUR
|
451,000
EUR
|
22,258
EUR
|
0
EUR
|
17,000
EUR
|
15,415
EUR
|
0
EUR
|
1,358
EUR
|
3,991
EUR
|
10,082
EUR
|
0
EUR
|
14,056
EUR
|